Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ant Capital Partners, formerly known as Nikko Antfactory, is a prominent Japanese private equity and venture capital firm headquartered in Tokyo. Established in 2000, the firm manages a diverse portfolio across three main strategies: private equity buyouts, secondary market transactions, and venture capital. The company has a significant historical track record in the life sciences and biotechnology sectors, having provided early-stage and growth capital to numerous Japanese biotech startups including NanoCarrier, CellSeed, and CanBas. Following a management-led restructuring and rebranding in 2008, the firm operates as an independent investment manager supported by major Japanese financial institutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nikko Antfactory.